Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 238 entries
Sorted by: Best Match Show Resources per page
Data on optical coherence tomography guidance for the management of angiographically intermediate left main bifurcation lesions.

Data in brief

Dato I, Burzotta F, Trani C, Romano A, Paraggio L, Aurigemma C, Porto I, Maria Leone A, Niccoli G, Crea F.
PMID: 28913391
Data Brief. 2017 Sep 05;14:635-638. doi: 10.1016/j.dib.2017.08.015. eCollection 2017 Oct.

The data presented in this article are related to the research article entitled "Optical coherence tomography guidance for the management of angiographically intermediate left main bifurcation lesions: early clinical experience" [1]. In this article we reports details about our...

Cite
Dato I, Burzotta F, Trani C, et al. Data on optical coherence tomography guidance for the management of angiographically intermediate left main bifurcation lesions. Data Brief. 2017;14:635-638doi: 10.1016/j.dib.2017.08.015.
Dato, I., Burzotta, F., Trani, C., Romano, A., Paraggio, L., Aurigemma, C., Porto, I., Maria Leone, A., Niccoli, G., & Crea, F. (2017). Data on optical coherence tomography guidance for the management of angiographically intermediate left main bifurcation lesions. Data in brief, 14635-638. https://doi.org/10.1016/j.dib.2017.08.015
Dato, Ilaria, et al. "Data on optical coherence tomography guidance for the management of angiographically intermediate left main bifurcation lesions." Data in brief vol. 14 (2017): 635-638. doi: https://doi.org/10.1016/j.dib.2017.08.015
Dato I, Burzotta F, Trani C, Romano A, Paraggio L, Aurigemma C, Porto I, Maria Leone A, Niccoli G, Crea F. Data on optical coherence tomography guidance for the management of angiographically intermediate left main bifurcation lesions. Data Brief. 2017 Sep 05;14:635-638. doi: 10.1016/j.dib.2017.08.015. eCollection 2017 Oct. PMID: 28913391; PMCID: PMC5587878.
Copy Download .nbib Format: NLM
Evolution of .

Bio-protocol

Miskinyte M, Gordo I.
PMID: 29094057
Bio Protoc. 2014 Sep 05;4(17). doi: 10.21769/BioProtoc.1227.

The genomes of species of

Cite
Miskinyte M, Gordo I. Evolution of . Bio Protoc. 2014;4(17)doi: 10.21769/BioProtoc.1227.
Miskinyte, M., & Gordo, I. (2014). Evolution of . Bio-protocol, 4(17), . https://doi.org/10.21769/BioProtoc.1227
Miskinyte, Migla, and Gordo, Isabel. "Evolution of ." Bio-protocol vol. 4,17 (2014). doi: https://doi.org/10.21769/BioProtoc.1227
Miskinyte M, Gordo I. Evolution of . Bio Protoc. 2014 Sep 05;4(17). doi: 10.21769/BioProtoc.1227. PMID: 29094057; PMCID: PMC5662142.
Copy Download .nbib Format: NLM
Lithuanian Green Movement (LGM).

Environmental science and pollution research international

Kanto I, Vainus L.
PMID: 24234605
Environ Sci Pollut Res Int. 1995 Nov;2(3):135. doi: 10.1007/BF02987523.

The Lithuanian Green Movement (LGM) was established in the Autumn of 1988. The LGM is an umbrella union of environmental clubs, groups and individuals for common activities, coordination and exchange of information. The LGM is a non-profit making and...

Cite
Kanto I, Vainus L. Lithuanian Green Movement (LGM). Environ Sci Pollut Res Int. 1995;2(3):135doi: 10.1007/BF02987523.
Kanto, I., & Vainus, L. (1995). Lithuanian Green Movement (LGM). Environmental science and pollution research international, 2(3), 135. https://doi.org/10.1007/BF02987523
Kanto, I, and Vainus, L. "Lithuanian Green Movement (LGM)." Environmental science and pollution research international vol. 2,3 (1995): 135. doi: https://doi.org/10.1007/BF02987523
Kanto I, Vainus L. Lithuanian Green Movement (LGM). Environ Sci Pollut Res Int. 1995 Nov;2(3):135. doi: 10.1007/BF02987523. PMID: 24234605.
Copy Download .nbib Format: NLM
Off-axis measurements of atmospheric trace gases by use of an airborne ultraviolet-visible spectrometer.

Applied optics

Petritoli A, Ravegnani F, Giovanelli G, Bortoli D, Bonafè U, Kostadinov I, Oulanovsky A.
PMID: 12269557
Appl Opt. 2002 Sep 20;41(27):5593-9. doi: 10.1364/ao.41.005593.

An airborne UV-visible spectrometer, the Gas Analyzer Spectrometer Correlating Optical Differences, airborne version (GASCOD/A4pi) was successfully operated during the Airborne Polar Experiment, Geophysica Aircraft in Antarctica airborne campaign from Ushuaia (54 degrees 49' S, 68 degrees 18' W), Argentina...

Cite
Petritoli A, Ravegnani F, Giovanelli G, et al. Off-axis measurements of atmospheric trace gases by use of an airborne ultraviolet-visible spectrometer. Appl Opt. 2002;41(27):5593-9doi: 10.1364/ao.41.005593.
Petritoli, A., Ravegnani, F., Giovanelli, G., Bortoli, D., Bonafè, U., Kostadinov, I., & Oulanovsky, A. (2002). Off-axis measurements of atmospheric trace gases by use of an airborne ultraviolet-visible spectrometer. Applied optics, 41(27), 5593-9. https://doi.org/10.1364/ao.41.005593
Petritoli, Andrea, et al. "Off-axis measurements of atmospheric trace gases by use of an airborne ultraviolet-visible spectrometer." Applied optics vol. 41,27 (2002): 5593-9. doi: https://doi.org/10.1364/ao.41.005593
Petritoli A, Ravegnani F, Giovanelli G, Bortoli D, Bonafè U, Kostadinov I, Oulanovsky A. Off-axis measurements of atmospheric trace gases by use of an airborne ultraviolet-visible spectrometer. Appl Opt. 2002 Sep 20;41(27):5593-9. doi: 10.1364/ao.41.005593. PMID: 12269557.
Copy Download .nbib Format: NLM
Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases.

Frontiers in microbiology

Koito A, Ikeda T.
PMID: 23431045
Front Microbiol. 2013 Feb 20;4:28. doi: 10.3389/fmicb.2013.00028. eCollection 2013.

Over 40% of the human genome is recognizable as having been derived from ancient retroelements, transported by an intracellular copy-and-paste process involving an RNA intermediate, with an additional few percent classified as DNA transposable elements. Endogenous retroviruses are long...

Cite
Koito A, Ikeda T. Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases. Front Microbiol. 2013;4:28doi: 10.3389/fmicb.2013.00028.
Koito, A., & Ikeda, T. (2013). Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases. Frontiers in microbiology, 428. https://doi.org/10.3389/fmicb.2013.00028
Koito, Atsushi, and Ikeda, Terumasa. "Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases." Frontiers in microbiology vol. 4 (2013): 28. doi: https://doi.org/10.3389/fmicb.2013.00028
Koito A, Ikeda T. Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases. Front Microbiol. 2013 Feb 20;4:28. doi: 10.3389/fmicb.2013.00028. eCollection 2013. PMID: 23431045; PMCID: PMC3576619.
Copy Download .nbib Format: NLM
Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coli.

Journal of biological engineering

Paixão L, Rodrigues L, Couto I, Martins M, Fernandes P, de Carvalho CC, Monteiro GA, Sansonetty F, Amaral L, Viveiros M.
PMID: 19835592
J Biol Eng. 2009 Oct 16;3:18. doi: 10.1186/1754-1611-3-18.

BACKGROUND: Efflux pump activity has been associated with multidrug resistance phenotypes in bacteria, compromising the effectiveness of antimicrobial therapy. The development of methods for the early detection and quantification of drug transport across the bacterial cell wall is a...

Cite
Paixão L, Rodrigues L, Couto I, et al. Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coli. J Biol Eng. 2009;3:18doi: 10.1186/1754-1611-3-18.
Paixão, L., Rodrigues, L., Couto, I., Martins, M., Fernandes, P., de Carvalho, C. C., Monteiro, G. A., Sansonetty, F., Amaral, L., & Viveiros, M. (2009). Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coli. Journal of biological engineering, 318. https://doi.org/10.1186/1754-1611-3-18
Paixão, Laura, et al. "Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coli." Journal of biological engineering vol. 3 (2009): 18. doi: https://doi.org/10.1186/1754-1611-3-18
Paixão L, Rodrigues L, Couto I, Martins M, Fernandes P, de Carvalho CC, Monteiro GA, Sansonetty F, Amaral L, Viveiros M. Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coli. J Biol Eng. 2009 Oct 16;3:18. doi: 10.1186/1754-1611-3-18. PMID: 19835592; PMCID: PMC2774284.
Copy Download .nbib Format: NLM
Retracted: Amelioration of Osteoporosis by Menatetrenone in Elderly Female Parkinson’s Disease Patients With Vitamin D Deficiency.

Bone

Sato Y, Honda Y, Kaji M, Asoh T, Hosokawa K, Kondo I, Satoh K.
PMID: 29278315
Bone. 2018 Jan;106:212. doi: 10.1016/j.bone.2017.10.006.

No abstract available.

Cite
Sato Y, Honda Y, Kaji M, et al. Retracted: Amelioration of Osteoporosis by Menatetrenone in Elderly Female Parkinson’s Disease Patients With Vitamin D Deficiency. Bone. 2018;106:212doi: 10.1016/j.bone.2017.10.006.
Sato, Y., Honda, Y., Kaji, M., Asoh, T., Hosokawa, K., Kondo, I., & Satoh, K. (2018). Retracted: Amelioration of Osteoporosis by Menatetrenone in Elderly Female Parkinson’s Disease Patients With Vitamin D Deficiency. Bone, 106212. https://doi.org/10.1016/j.bone.2017.10.006
Sato, Y, et al. "Retracted: Amelioration of Osteoporosis by Menatetrenone in Elderly Female Parkinson’s Disease Patients With Vitamin D Deficiency." Bone vol. 106 (2018): 212. doi: https://doi.org/10.1016/j.bone.2017.10.006
Sato Y, Honda Y, Kaji M, Asoh T, Hosokawa K, Kondo I, Satoh K. Retracted: Amelioration of Osteoporosis by Menatetrenone in Elderly Female Parkinson’s Disease Patients With Vitamin D Deficiency. Bone. 2018 Jan;106:212. doi: 10.1016/j.bone.2017.10.006. PMID: 29278315.
Copy Download .nbib Format: NLM
Fitness Measurements of Evolved .

Bio-protocol

Miskinyte M, Gordo I.
PMID: 29104882
Bio Protoc. 2014 Sep 05;4(17). doi: 10.21769/BioProtoc.1228.

Bacteria can adapt very rapidly to novel selective pressures. In the transition from commensalism to pathogenicity bacteria have to face and adapt to the host immune system. Specifically, the antagonistic interaction imposed by one of the first line of...

Cite
Miskinyte M, Gordo I. Fitness Measurements of Evolved . Bio Protoc. 2014;4(17)doi: 10.21769/BioProtoc.1228.
Miskinyte, M., & Gordo, I. (2014). Fitness Measurements of Evolved . Bio-protocol, 4(17), . https://doi.org/10.21769/BioProtoc.1228
Miskinyte, Migla, and Gordo, Isabel. "Fitness Measurements of Evolved ." Bio-protocol vol. 4,17 (2014). doi: https://doi.org/10.21769/BioProtoc.1228
Miskinyte M, Gordo I. Fitness Measurements of Evolved . Bio Protoc. 2014 Sep 05;4(17). doi: 10.21769/BioProtoc.1228. PMID: 29104882; PMCID: PMC5665430.
Copy Download .nbib Format: NLM
A Case of Frequently Relapsing Minimal-Change Nephrotic Syndrome with Steroid-Induced Psychiatric Syndrome Treated by Low-Dose, Short-Term Steroid Therapy in Combination with Cyclosporine.

Case reports in nephrology and dialysis

Kondo I, Arai Y, Hamada A, Yamada K, Shioji S, Sakamoto E, Katagiri D, Tada M, Hinoshita F.
PMID: 32002410
Case Rep Nephrol Dial. 2020 Jan 10;10(1):1-8. doi: 10.1159/000505313. eCollection 2020.

Adults with minimal-change nephrotic syndrome (MCNS) generally receive oral prednisolone (PSL) at an initial dosage of 1.0 mg/kg/day for a minimum of 4 weeks, with 80% of patients achieving clinical remission. However, relapses are frequent, necessitating repeated treatment with...

Cite
Kondo I, Arai Y, Hamada A, et al. A Case of Frequently Relapsing Minimal-Change Nephrotic Syndrome with Steroid-Induced Psychiatric Syndrome Treated by Low-Dose, Short-Term Steroid Therapy in Combination with Cyclosporine. Case Rep Nephrol Dial. 2020;10(1):1-8doi: 10.1159/000505313.
Kondo, I., Arai, Y., Hamada, A., Yamada, K., Shioji, S., Sakamoto, E., Katagiri, D., Tada, M., & Hinoshita, F. (2020). A Case of Frequently Relapsing Minimal-Change Nephrotic Syndrome with Steroid-Induced Psychiatric Syndrome Treated by Low-Dose, Short-Term Steroid Therapy in Combination with Cyclosporine. Case reports in nephrology and dialysis, 10(1), 1-8. https://doi.org/10.1159/000505313
Kondo, Isao, et al. "A Case of Frequently Relapsing Minimal-Change Nephrotic Syndrome with Steroid-Induced Psychiatric Syndrome Treated by Low-Dose, Short-Term Steroid Therapy in Combination with Cyclosporine." Case reports in nephrology and dialysis vol. 10,1 (2020): 1-8. doi: https://doi.org/10.1159/000505313
Kondo I, Arai Y, Hamada A, Yamada K, Shioji S, Sakamoto E, Katagiri D, Tada M, Hinoshita F. A Case of Frequently Relapsing Minimal-Change Nephrotic Syndrome with Steroid-Induced Psychiatric Syndrome Treated by Low-Dose, Short-Term Steroid Therapy in Combination with Cyclosporine. Case Rep Nephrol Dial. 2020 Jan 10;10(1):1-8. doi: 10.1159/000505313. eCollection 2020. PMID: 32002410; PMCID: PMC6984147.
Copy Download .nbib Format: NLM
Recurrent chest pain: 'what is essential is invisible to the eye?'.

European heart journal supplements : journal of the European Society of Cardiology

D'Amario D, De Vita A, Vergallo R, Porto I, Galli M, Crea F.
PMID: 30996700
Eur Heart J Suppl. 2019 Apr;21:C11-C14. doi: 10.1093/eurheartj/suz040. Epub 2019 Apr 10.

No abstract available.

Cite
D'Amario D, De Vita A, Vergallo R, et al. Recurrent chest pain: 'what is essential is invisible to the eye?'. Eur Heart J Suppl. 2019;21:C11-C14doi: 10.1093/eurheartj/suz040.
D'Amario, D., De Vita, A., Vergallo, R., Porto, I., Galli, M., & Crea, F. (2019). Recurrent chest pain: 'what is essential is invisible to the eye?'. European heart journal supplements : journal of the European Society of Cardiology, 21C11-C14. https://doi.org/10.1093/eurheartj/suz040
D'Amario, Domenico, et al. "Recurrent chest pain: 'what is essential is invisible to the eye?'." European heart journal supplements : journal of the European Society of Cardiology vol. 21 (2019): C11-C14. doi: https://doi.org/10.1093/eurheartj/suz040
D'Amario D, De Vita A, Vergallo R, Porto I, Galli M, Crea F. Recurrent chest pain: 'what is essential is invisible to the eye?'. Eur Heart J Suppl. 2019 Apr;21:C11-C14. doi: 10.1093/eurheartj/suz040. Epub 2019 Apr 10. PMID: 30996700; PMCID: PMC6456887.
Copy Download .nbib Format: NLM
[Pain management in children with erythromelalgia: case report].

Brazilian journal of anesthesiology (Elsevier)

Bortoli EI, Sakata RK.
PMID: 29402440
Braz J Anesthesiol. 2018 Sep - Oct;68(5):531-534. doi: 10.1016/j.bjan.2017.12.009. Epub 2018 Feb 03.

Erythromelalgia is a neuropathic pain syndrome due to an autosomal dominant gene, characterized by erythema, increased skin temperature and burning pain in hands and feet, whose treatment is often unsatisfactory. In this paper, we report a case of a...

Cite
Bortoli EI, Sakata RK. Tratamento da dor em criança com eritromelalgia: relato de caso. [Pain management in children with erythromelalgia: case report]. Braz J Anesthesiol. 2018;68(5):531-534doi: 10.1016/j.bjan.2017.12.009.
Bortoli, E. I., & Sakata, R. K. (2018). Tratamento da dor em criança com eritromelalgia: relato de caso. [Pain management in children with erythromelalgia: case report]. Brazilian journal of anesthesiology (Elsevier), 68(5), 531-534. https://doi.org/10.1016/j.bjan.2017.12.009
Bortoli, Estela Irene, and Sakata, Rioko Kimiko. "Tratamento da dor em criança com eritromelalgia: relato de caso." [Pain management in children with erythromelalgia: case report]. Brazilian journal of anesthesiology (Elsevier) vol. 68,5 (2018): 531-534. doi: https://doi.org/10.1016/j.bjan.2017.12.009
Bortoli EI, Sakata RK. Tratamento da dor em criança com eritromelalgia: relato de caso. [Pain management in children with erythromelalgia: case report]. Braz J Anesthesiol. 2018 Sep - Oct;68(5):531-534. doi: 10.1016/j.bjan.2017.12.009. Epub 2018 Feb 03. Portuguese. PMID: 29402440.
Copy Download .nbib Format: NLM
Silencing of the nucleocytoplasmic shuttling protein karyopherin a2 promotes cell-cycle arrest and apoptosis in glioblastoma multiforme.

Oncotarget

Martinez-Olivera R, Datsi A, Stallkamp M, Köller M, Kohtz I, Pintea B, Gousias K.
PMID: 30323892
Oncotarget. 2018 Sep 11;9(71):33471-33481. doi: 10.18632/oncotarget.26033. eCollection 2018 Sep 11.

We have previously shown that the nucleocytoplasmic carrier karyopherin a2 (KPNA2) is overexpressed in glioblastoma multiforme (GBM) whereas its expression is inversely associated with patient prognosis. However, the promoting role of KPNA2 in gliomagenesis is still poorly understood. This...

Cite
Martinez-Olivera R, Datsi A, Stallkamp M, et al. Silencing of the nucleocytoplasmic shuttling protein karyopherin a2 promotes cell-cycle arrest and apoptosis in glioblastoma multiforme. Oncotarget. 2018;9(71):33471-33481doi: 10.18632/oncotarget.26033.
Martinez-Olivera, R., Datsi, A., Stallkamp, M., Köller, M., Kohtz, I., Pintea, B., & Gousias, K. (2018). Silencing of the nucleocytoplasmic shuttling protein karyopherin a2 promotes cell-cycle arrest and apoptosis in glioblastoma multiforme. Oncotarget, 9(71), 33471-33481. https://doi.org/10.18632/oncotarget.26033
Martinez-Olivera, Ramon, et al. "Silencing of the nucleocytoplasmic shuttling protein karyopherin a2 promotes cell-cycle arrest and apoptosis in glioblastoma multiforme." Oncotarget vol. 9,71 (2018): 33471-33481. doi: https://doi.org/10.18632/oncotarget.26033
Martinez-Olivera R, Datsi A, Stallkamp M, Köller M, Kohtz I, Pintea B, Gousias K. Silencing of the nucleocytoplasmic shuttling protein karyopherin a2 promotes cell-cycle arrest and apoptosis in glioblastoma multiforme. Oncotarget. 2018 Sep 11;9(71):33471-33481. doi: 10.18632/oncotarget.26033. eCollection 2018 Sep 11. PMID: 30323892; PMCID: PMC6173355.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 238 entries